SCHEMBL38650985

SCHEMBL38650985

Cn1cc(-c2ccc(CO)nc2N)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMARCA2 P51531 1/20 0.45
SMARCA4 P51532 1/20 0.45
LRRK2 Q5S007 3/20 0.44
MAP4K4 O95819 2/20 0.42
BRD4 O60885 1/20 0.41
GRM2 Q14416 1/20 0.40
KDR P35968 4/20 0.39
BTK Q06187 2/20 0.39
CCNC P24863 3/20 0.39
CDK8 P49336 3/20 0.39
LCK P06239 1/20 0.39
CHEK1 O14757 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
CCNA1 P78396 1/20 0.39
AURKB Q96GD4 3/20 0.38
PLK4 O00444 1/20 0.38
AURKA O14965 1/20 0.38
ROCK2 O75116 1/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12460416 0.80 LRRK2 (0.49) SMARCA2SMARCA4LRRK2MAP4K4BRD4
SCHEMBL12459916 0.78 LRRK2 (0.51) SMARCA2SMARCA4LRRK2MAP4K4BRD4
SCHEMBL12138433 0.78 SMARCA2 (0.43) SMARCA2SMARCA4LRRK2MAP4K4BRD4
SCHEMBL3702318 0.75 LRRK2 (0.45) SMARCA2SMARCA4LRRK2MAP4K4BRD4
SCHEMBL38650887 0.74 SMARCA2 (0.46) SMARCA2SMARCA4LRRK2MAP4K4GRM2
SCHEMBL24920665 0.73 IRAK4 (0.47) LRRK2KDRCHEK1FYNCSF1R
SCHEMBL21753343 0.72 MAPT (0.44) LRRK2MAP4K4CCNCCDK8FYN
SCHEMBL30274584 0.72 CLK2 (0.43) LRRK2BTKCHEK1AURKBAURKA
SCHEMBL24007658 0.72 CLK2 (0.43) LRRK2BTKCHEK1AURKBAURKA
SCHEMBL38650925 0.71 SMARCA2 (0.65) SMARCA2SMARCA4LRRK2MAP4K4BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010963-A Polycyclic SMARCA2 inhibitor and application thereof 上海和誉生物医药科技有限公司 2026-05-12 CN disclosed